Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Pardi

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Vaccines|April 27, 2026
Comparison of Vaccine Platforms for Machupo VirusRachel Erickson, Hiromi Muramatsu, Sachchidanand Tiwari, et al.
BMC Molecular Biology|June 14, 2008
TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its functionOrsolya Bereczki, Zsuzsanna Ujfaludi, Norbert Pardi, et al.
The Journal of Biological Chemistry|October 16, 2007
Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and Ark mRNA levelLászló Bodai, Norbert Pardi, Zsuzsanna Ujfaludi, et al.
Molecular Therapy. Nucleic Acids|August 27, 2024
The roles of CD4<sup>+</sup> T cell help, sex, and dose in the induction of protective CD8<sup>+</sup> T cells against a lethal poxvirus by mRNA-LNP vaccinesSamita Kafle, Brian Montoya, Lingjuan Tang, et al.
Science Translational Medicine|January 10, 2020
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in miceElinor Willis, Norbert Pardi, Kaela Parkhouse, et al.
Vaccine|October 12, 2020
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccinePhilip C LaTourette, Sita Awasthi, Angela Desmond, et al.
Bio-Protocol|November 1, 2021
Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNAElissa Everton, Fatima Rizvi, Anna R Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2022
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccineHiromi Muramatsu, Kieu Lam, Csaba Bajusz, et al.
Plos Pathogens|July 28, 2020
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infectionKevin P Egan, Lauren M Hook, Alexis Naughton, et al.
Antibodies (Basel, Switzerland)|July 25, 2023
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in ImmunotherapyChristopher Chung, Sagar B Kudchodkar, Curtis N Chung, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Vaccines|April 27, 2026
Comparison of Vaccine Platforms for Machupo VirusRachel Erickson, Hiromi Muramatsu, Sachchidanand Tiwari, et al.
BMC Molecular Biology|June 14, 2008
TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its functionOrsolya Bereczki, Zsuzsanna Ujfaludi, Norbert Pardi, et al.
The Journal of Biological Chemistry|October 16, 2007
Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and Ark mRNA levelLászló Bodai, Norbert Pardi, Zsuzsanna Ujfaludi, et al.
Molecular Therapy. Nucleic Acids|August 27, 2024
The roles of CD4<sup>+</sup> T cell help, sex, and dose in the induction of protective CD8<sup>+</sup> T cells against a lethal poxvirus by mRNA-LNP vaccinesSamita Kafle, Brian Montoya, Lingjuan Tang, et al.
Science Translational Medicine|January 10, 2020
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in miceElinor Willis, Norbert Pardi, Kaela Parkhouse, et al.
Vaccine|October 12, 2020
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccinePhilip C LaTourette, Sita Awasthi, Angela Desmond, et al.
Bio-Protocol|November 1, 2021
Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNAElissa Everton, Fatima Rizvi, Anna R Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2022
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccineHiromi Muramatsu, Kieu Lam, Csaba Bajusz, et al.
Plos Pathogens|July 28, 2020
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infectionKevin P Egan, Lauren M Hook, Alexis Naughton, et al.
Antibodies (Basel, Switzerland)|July 25, 2023
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in ImmunotherapyChristopher Chung, Sagar B Kudchodkar, Curtis N Chung, et al.
Pageof 15